U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
OTL-101
Preferred Name English
SIMOLADAGENE AUTOTEMCEL
USAN   INN  
Official Name English
CELL BASED DRUG PRODUCT CONSISTING OF CELLS THAT HAVE BEEN GENETICALLY MODIFIED EX VIVO. IT INCLUDES AUTOLOGOUS CD34+ HEMATOPOIETIC STEM CELLS (HSCS) FROM SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY (ADA-SCID) SUBJECTS TRANSDUC
Common Name English
SIMOLADAGENE AUTOTEMCEL [USAN]
Common Name English
simoladagene autotemcel [INN]
Common Name English
Simoladagene autotemcel [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
MOD3RG31RS
Created by admin on Wed Apr 02 03:47:50 GMT 2025 , Edited by admin on Wed Apr 02 03:47:50 GMT 2025
PRIMARY
SMS_ID
100000174710
Created by admin on Wed Apr 02 03:47:50 GMT 2025 , Edited by admin on Wed Apr 02 03:47:50 GMT 2025
PRIMARY
INN
11042
Created by admin on Wed Apr 02 03:47:50 GMT 2025 , Edited by admin on Wed Apr 02 03:47:50 GMT 2025
PRIMARY
USAN
FG-30
Created by admin on Wed Apr 02 03:47:50 GMT 2025 , Edited by admin on Wed Apr 02 03:47:50 GMT 2025
PRIMARY
NCI_THESAURUS
C171810
Created by admin on Wed Apr 02 03:47:50 GMT 2025 , Edited by admin on Wed Apr 02 03:47:50 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966